Literature DB >> 24672678

The complement system: history, pathways, cascade and inhibitors.

P N Nesargikar, B Spiller, R Chavez.   

Abstract

Since its discovery in the 19th century, the complement system has developed into a clinically significant entity. The complement system has been implicated in a variety of clinical conditions, from autoimmune diseases to ischemia-reperfusion injury in transplantation. This article charts the historical progress of our understanding of the complement system and provides a synopsis on the activation pathways and its inherent regulators.

Entities:  

Keywords:  complement activation; complement cascade; complement history; complement inhibitors; complement system

Year:  2012        PMID: 24672678      PMCID: PMC3956958          DOI: 10.1556/EuJMI.2.2012.2.2

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  97 in total

Review 1.  Complement and innate immunity.

Authors:  W C Song; M R Sarrias; J D Lambris
Journal:  Immunopharmacology       Date:  2000-08

2.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

3.  The birth of immunology. II. Metchnikoff and his critics.

Authors:  A I Tauber; L Chernyak
Journal:  Cell Immunol       Date:  1989-07       Impact factor: 4.868

Review 4.  The central role of the alternative complement pathway in human disease.

Authors:  Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties.

Authors:  Vitaliy Gavrilyuk; Sergey Kalinin; Brian S Hilbush; Andrew Middlecamp; Susan McGuire; Dale Pelligrino; Guy Weinberg; Douglas L Feinstein
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

6.  Isolation and characterization of a mannan-binding protein from rabbit liver.

Authors:  T Kawasaki; R Etoh; I Yamashina
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

7.  C5a induces tissue factor activity on endothelial cells.

Authors:  K Ikeda; K Nagasawa; T Horiuchi; T Tsuru; H Nishizaka; Y Niho
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

8.  Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2.

Authors:  T Vorup-Jensen; S V Petersen; A G Hansen; K Poulsen; W Schwaeble; R B Sim; K B Reid; S J Davis; S Thiel; J C Jensenius
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 9.  Biological effects of C1 inhibitor.

Authors:  Alvin E Davis
Journal:  Drug News Perspect       Date:  2004-09

10.  The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.

Authors:  J A Manni; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

View more
  74 in total

Review 1.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

2.  Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.

Authors:  Ainhoa Perez-Diez; Chun-Shu Wong; Xiangdong Liu; Harry Mystakelis; Jian Song; Yong Lu; Virginia Sheikh; Jeffrey S Bourgeois; Andrea Lisco; Elizabeth Laidlaw; Cornelia Cudrici; Chengsong Zhu; Quan-Zhen Li; Alexandra F Freeman; Peter R Williamson; Megan Anderson; Gregg Roby; John S Tsang; Richard Siegel; Irini Sereti
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 3.  Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis.

Authors:  Siew-Wai Fong; R Manjunatha Kini; Lisa F P Ng
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

4.  Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Authors:  Rebecca L McCullough; Megan R McMullen; Megan M Sheehan; Kyle L Poulsen; Sanjoy Roychowdhury; Dian J Chiang; Michele T Pritchard; Juan Caballeria; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

Review 5.  Protection of host cells by complement regulators.

Authors:  Christoph Q Schmidt; John D Lambris; Daniel Ricklin
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

6.  Alternative complement pathway component Factor D contributes to efficient clearance of tissue debris following acute CCl₄-induced injury.

Authors:  Gail A Cresci; Daniela Allende; Megan R McMullen; Laura E Nagy
Journal:  Mol Immunol       Date:  2014-11-15       Impact factor: 4.407

7.  Inhibition of the alternative complement pathway preserves photoreceptors after retinal injury.

Authors:  J Harry Sweigard; Hidetaka Matsumoto; Kaylee E Smith; Leo A Kim; Eleftherios I Paschalis; Yoko Okonuki; Alexandra Castillejos; Keiko Kataoka; Eiichi Hasegawa; Ryoji Yanai; Deeba Husain; John D Lambris; Demetrios Vavvas; Joan W Miller; Kip M Connor
Journal:  Sci Transl Med       Date:  2015-07-22       Impact factor: 17.956

Review 8.  Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Jacob Danoff; Hassan Madani; Adam Sugarman; Florin Niculescu; Petru A Mircea; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

9.  Engineered materials for in vivo delivery of genome-editing machinery.

Authors:  Sheng Tong; Buhle Moyo; Ciaran M Lee; Kam Leong; Gang Bao
Journal:  Nat Rev Mater       Date:  2019-10-04       Impact factor: 66.308

10.  Fitness outcomes in relation to individual variation in constitutive innate immune function.

Authors:  Michael J Roast; Nataly Hidalgo Aranzamendi; Marie Fan; Niki Teunissen; Matthew D Hall; Anne Peters
Journal:  Proc Biol Sci       Date:  2020-11-04       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.